Skip to content

Arthrex® AR-7209Recalls & reported problems

Arthrex, Inc. · #2 FIBERSTICK, #2 FIBERWIRE · Class 2 · Implant

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00888867041370), received between Feb 8, 2019 and Nov 14, 2024 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Split, Cut or Torn” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Material Split, Cut or Torn1
  • Patient Device Interaction Problem1
  • Patient-Device Incompatibility1

Patient problems

  • Anaphylactic Shock1
  • Insufficient Information1
  • Patient Problem/Medical Problem1
  • Reaction1
  • Urticaria1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 14, 2024Material Split, Cut or Torn; Material Split, Cut or Torn

    ON 10/24/2024, IT WAS REPORTED BY AN ARTHREX SUBSIDIARY EMPLOYEE VIA (B)(4) THAT AN AR-2923PHS SUTURE ANCHOR DOES NOT PERFORM ITS FUNCTION, AND AN AR-7209 FIBERSTICK TORE. THIS OCCURRED DURING A HIP ARTHROSCOPY PROCEDURE ON (B)(6) 2024.

    Patient problems: Insufficient Information

    MAUDE report 20685993 ↗
  • InjuryFeb 8, 2019Patient-Device Incompatibility; Patient Device Interaction Problem; Patient-Device Incompatibility; Patient Device Interaction Problem

    IT WAS ORIGINALLY REPORTED THAT THE PATIENT HAD SUFFERED A SHOULDER INJURY IN 2011 WHILE WORKING. ON (B)(6) 2013 SHE UNDERWENT A SHOULDER PROCEDURE DURING WHICH AN ARTHREX AR-7209, LOT :10667 (#2 FIBERSTICK, #2 FIBERWIRE) AND AN AR-7200 LOT: UNKNOWN (FIBERWIRE BRAIDED PB #2 SUTURE, BLUE W/NEEDLE) WERE UTILIZED. FOLLOWING THE (B)(6) 2013 SURGERY THE PATIENT BEGAN TO EXPERIENCE REACTION TYPE SYMPTOMS WHICH THE PATIENT REPORTED TO ARTHREX ON (B)(6) 2014 ((B)(4), MEDWATCH 1220246-2014-00200). AT THAT TIME THE PATIENT REPORTED THAT SHE HAD BEEN HAVING HIVES WITH A POSSIBLE REACTION TO THE FIBERWIRE. THE PATIENT ALSO REPORTED THAT SHE HAD BEEN SEEN BY A DERMATOLOGIST BUT THE OUTCOME HAD BEEN INCONCLUSIVE AT THAT TIME. NO FURTHER INFORMATION WAS PROVIDED TO ARTHREX. ON JANUARY 9, 2019, ARTHREX RECEIVED A CD FROM THE PATIENT CONTAINING VOLUMINOUS MEDICAL RECORDS. THE MEDICAL RECORDS NOTE THE PATIENT CONTINUED TO HAVE ISSUES FOLLOWING HER (B)(6) 2013 RIGHT SHOULDER SURGERY INCLUDING ANAPHYLACTIC SHOCK EPISODES, ANGIOEDEMA AND URTICARIA. THE PATIENT WAS SEEN BY MULTIPLE MEDICAL PROFESSIONALS TO DETERMINE WHAT WAS CAUSING HER FREQUENT EPISODES OF ANAPHYLAXIS. IT WAS IDENTIFIED VIA A PATCH TES

    Patient problems: Anaphylactic Shock; Patient Problem/Medical Problem; Reaction; Urticaria

    MAUDE report 8321453 ↗

Other SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE devices

All SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.